Using a cohort of early, untreated RA patients (Supplementary Table 1), we assessed protein concentrations of GM-CSF, IL-1β and IL-1α in blood samples collected at diagnosis and after two years of anti-rheumatic therapy. This evidence concerns the gene CSF2 and rheumatoid arthritis.